Gitte S. Jensen
Research Subjects
Gitte S. Jensen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Aaron N. Hart
3 shared publications- Alexander G. Schauss
Natural and Medicinal Products Research, AIMBR Life Sciences, 4117 South Meridian, Puyallup, Washington 98373, USA
2 shared publications I. Yoon
Diamond V Mills, 838 1st Street NW, Cedar Rapids, IA 52407, USA
2 shared publicationsChristian Drapeau
1 shared publication- David J. Schaeffer
Department of Clinical Veterinary Medicine, College of Veterinary Medicine University of Illinois Urbana‐Champaign Illinois USA
1 shared publication J. Alex Cruickshank
1 shared publication
Latest Publications
- 1 November 2008
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 31 (6) , 487-500
Yeast culture has anti-inflammatory effects and specifically activates NK cells
- 1 November 2008
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 31 (6) , 487-500
Yeast culture has anti-inflammatory effects and specifically activates NK cells
- Open Access
- 22 August 2008
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 56 (18) , 8326-8333
In Vitro and in Vivo Antioxidant and Anti-inflammatory Capacities of an Antioxidant-Rich Fruit and Berry Juice Blend. Results of a Pilot and Randomized, Double-Blinded, Placebo-Controlled, Crossover Study
This study investigated the in vitro and in vivo antioxidant and anti-inflammatory properties of a juice blend (JB), MonaVie Active, containing a mixture of fruits and berries with known antioxidant activity, including açai, a palm fruit, as the predominant ingredient. The phytochemical antioxidants in the JB are primarily in the form of anthocyanins, predominantly cyanidin 3-rutoside, cyanidin 3-diglycoside, and cyanidin 3-glucoside. The cell-based antioxidant protection of erythrocytes (CAP-e) assay demonstrated that antioxidants in the JB penetrated and protected cells from oxidative damage (p < 0.001), whereas polymorphonuclear cells showed reduced formation of reactive oxygen species (p < 0.003) and reduced migration toward three different pro-inflammatory chemoattractants: fmlp (p < 0.001), leukotriene B4 (p < 0.05), and IL-8 (p < 0.03). A randomized, double-blinded, placebo-controlled, crossover trial with 12 healthy subjects examined the JB’s antioxidant activity in vivo. Blood samples at baseline, 1 h, and 2 h following consumption of the JB or placebo were tested for antioxidant capacity using several antioxidant assays and the TBARS assay, a measure of lipid peroxidation. A within subject comparison showed an increase in serum antioxidants at 1 h (p < 0.03) and 2 h (p < 0.015), as well as inhibition of lipid peroxidation at 2 h (p < 0.01) postconsumption.
- 22 August 2008
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 56 (18) , 8326-8333
Open AccessIn Vitro and in Vivo Antioxidant and Anti-inflammatory Capacities of an Antioxidant-Rich Fruit and Berry Juice Blend. Results of a Pilot and Randomized, Double-Blinded, Placebo-Controlled, Crossover Study
This study investigated the in vitro and in vivo antioxidant and anti-inflammatory properties of a juice blend (JB), MonaVie Active, containing a mixture of fruits and berries with known antioxidant activity, including açai, a palm fruit, as the predominant ingredient. The phytochemical antioxidants in the JB are primarily in the form of anthocyanins, predominantly cyanidin 3-rutoside, cyanidin 3-diglycoside, and cyanidin 3-glucoside. The cell-based antioxidant protection of erythrocytes (CAP-e) assay demonstrated that antioxidants in the JB penetrated and protected cells from oxidative damage (p < 0.001), whereas polymorphonuclear cells showed reduced formation of reactive oxygen species (p < 0.003) and reduced migration toward three different pro-inflammatory chemoattractants: fmlp (p < 0.001), leukotriene B4 (p < 0.05), and IL-8 (p < 0.03). A randomized, double-blinded, placebo-controlled, crossover trial with 12 healthy subjects examined the JB’s antioxidant activity in vivo. Blood samples at baseline, 1 h, and 2 h following consumption of the JB or placebo were tested for antioxidant capacity using several antioxidant assays and the TBARS assay, a measure of lipid peroxidation. A within subject comparison showed an increase in serum antioxidants at 1 h (p < 0.03) and 2 h (p < 0.015), as well as inhibition of lipid peroxidation at 2 h (p < 0.01) postconsumption.
- Open Access
- 8 April 2008
- Published by The Kielanowski Institute of Animal Physiology and Nutrition, PAS in Journal of Animal and Feed Sciences
- Vol. 17 (2) , 247-252
Nutritional yeast culture has specific anti-microbial properties without affecting healthy flora. Preliminary results
The objective of this study was to perform a preliminary assessment of the potential antimicrobial effects in vitro of nutritional yeast culture (Diamond V XP™), containing Saccharomyces cerevisiae , media on which it was grown, and metabolites produced during fermentation. It was tested...
- 8 April 2008
- Published by The Kielanowski Institute of Animal Physiology and Nutrition, PAS in Journal of Animal and Feed Sciences
- Vol. 17 (2) , 247-252
Open AccessNutritional yeast culture has specific anti-microbial properties without affecting healthy flora. Preliminary results
The objective of this study was to perform a preliminary assessment of the potential antimicrobial effects in vitro of nutritional yeast culture (Diamond V XP™), containing Saccharomyces cerevisiae , media on which it was grown, and metabolites produced during fermentation. It was tested...
- 1 June 2007
- Published by Elsevier in Nutrition Research
- Vol. 27 (6) , 327-335
An antiinflammatory immunogen from yeast culture induces activation and alters chemokine receptor expression on human natural killer cells and B lymphocytes in vitro
- 1 June 2007
- Published by Elsevier in Nutrition Research
- Vol. 27 (6) , 327-335
An antiinflammatory immunogen from yeast culture induces activation and alters chemokine receptor expression on human natural killer cells and B lymphocytes in vitro
- 1 May 2006
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 12 (4) , 409-416
Immunomodulation by SanPharma Fungal Metabolic Products
In the present study, a series of fungal metabolite products from SanPharma (Dohren, Germany) were tested for effects on human peripheral blood leukocytes in vitro using standard immunologic methods. Therapeutic strategies used in German biological medicine often include treatment (oral, nasal, rectal, topical, or injection) with fungal or bacterial products, also known as "isopathic remedies," of which some are limited to metabolic products, whereas others include microbial cell lysates and cell wall fragments as well. The SanPharma products are based on metabolites, and do not contain microbial cell wall compounds. Activation of natural killer (NK) cells was evaluated by cell surface immunostaining using CD3, CD56, CD69, and CD25 monoclonal antibodies. Production of interferon-gamma was evaluated by enzyme-linked immunoabsorbent assay (ELISA) on supernatants collected after 5 days' culture of peripheral blood mononuclear cells (PBMC). Direct mitogenic effect was assessed using the lipophilic membrane dye PHK26 (Sigma-Aldrich, St. Louis, MO) in a fluorescence-based proliferation assay, in which fluorescence intensity is reduced upon cell divisions. Cell viability upon exposure to fungal metabolites was assessed using propidium iodide staining and flow cytometry. All fungal metabolite products specifically induced the expression of the CD69 marker on human CD3-negative, CD56-positive NK cells, but not CD3-positive T cells, in vitro, as shown by the induction of the CD69 marker on up to 50% of NK cells after 18 hours' culture with metabolites. Only one of the five metabolite products, Roqueforti, induced cyclooxygenase-2 (COX-2), indicating that nuclear factor-kappaB (NFkappaB)-mediated signaling may not have been involved in the NK activation by the other four products. The Notatum product reduced baseline levels of COX-2, indicating an anti-inflammatory effect. No evidence of toxic or mitogenic effects was found. The fungal metabolite products from SanPharma specifically activate human NK cells in vitro.
- 1 May 2006
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 12 (4) , 409-416
Immunomodulation by SanPharma Fungal Metabolic Products
In the present study, a series of fungal metabolite products from SanPharma (Dohren, Germany) were tested for effects on human peripheral blood leukocytes in vitro using standard immunologic methods. Therapeutic strategies used in German biological medicine often include treatment (oral, nasal, rectal, topical, or injection) with fungal or bacterial products, also known as "isopathic remedies," of which some are limited to metabolic products, whereas others include microbial cell lysates and cell wall fragments as well. The SanPharma products are based on metabolites, and do not contain microbial cell wall compounds. Activation of natural killer (NK) cells was evaluated by cell surface immunostaining using CD3, CD56, CD69, and CD25 monoclonal antibodies. Production of interferon-gamma was evaluated by enzyme-linked immunoabsorbent assay (ELISA) on supernatants collected after 5 days' culture of peripheral blood mononuclear cells (PBMC). Direct mitogenic effect was assessed using the lipophilic membrane dye PHK26 (Sigma-Aldrich, St. Louis, MO) in a fluorescence-based proliferation assay, in which fluorescence intensity is reduced upon cell divisions. Cell viability upon exposure to fungal metabolites was assessed using propidium iodide staining and flow cytometry. All fungal metabolite products specifically induced the expression of the CD69 marker on human CD3-negative, CD56-positive NK cells, but not CD3-positive T cells, in vitro, as shown by the induction of the CD69 marker on up to 50% of NK cells after 18 hours' culture with metabolites. Only one of the five metabolite products, Roqueforti, induced cyclooxygenase-2 (COX-2), indicating that nuclear factor-kappaB (NFkappaB)-mediated signaling may not have been involved in the NK activation by the other four products. The Notatum product reduced baseline levels of COX-2, indicating an anti-inflammatory effect. No evidence of toxic or mitogenic effects was found. The fungal metabolite products from SanPharma specifically activate human NK cells in vitro.